{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:01:35Z","timestamp":1792155695292,"version":"4.4.0"},"reference-count":85,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Type 1 diabetes (T1D) affects over 2 million people in the United States and has no known cure. The discovery and first use of insulin in humans 102 years ago marked a revolutionary course of treatment for the disease, and although the formulations and delivery systems have advanced, insulin administration remains the standard of care today. While improved treatment options represent notable progress in T1D management, finding a functional cure for the disease remains the ultimate goal. Approaches to curing T1D have historically focused on blunting the autoimmune response, although sustained effects of immune modulation have proven elusive. Islet transplant therapies have also proven effective, although a lack of available donor tissue and the need for immunosuppression to prevent both host\u2013graft rejection and the autoimmune response have reserved such treatments for those who already require immunosuppressive regimens for other reasons or undergo severe hypoglycemic events in conjunction with hypoglycemic unawareness. With the advent of human stem cell research, the focus has shifted toward generating an abundance of allogeneic, functional beta-like cells that can be transplanted into the patients. Immunoisolation devices have also shown some promise as a method of preventing immune rejection and the autoimmune destruction of transplanted cells. Finally, advances in new immune therapies, if used in the early stages of T1D progression, have proven to delay the onset of diabetes. Stem cell-based therapies are a promising approach to curing T1D. The ongoing clinical trials show some success, although they currently require immunosuppressant agents. Encapsulation devices provide a method of immunoisolation that does not require immunosuppression; however, the devices tested thus far eventually lead to cell death and fibrotic tissue growth. Substantial research efforts are underway to develop new approaches to protect the stem cell-derived beta cells upon transplantation.<\/jats:p>","DOI":"10.1089\/dia.2024.0498","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:34:31Z","timestamp":1738812871000},"page":"413-421","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Cure for Type 1 Diabetes: Are We There Yet?"],"prefix":"10.1177","volume":"27","author":[{"given":"Christopher","family":"Schaaf","sequence":"first","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center, Denver, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-7304","authenticated-orcid":false,"given":"Lori","family":"Sussel","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center, Denver, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"3","key":"e_1_3_5_2_2","first-page":"141","article-title":"Pancreatic extracts in the treatment of diabetes mellitus","volume":"12","author":"Banting FG","year":"1922","unstructured":"Banting FG, , Best CH, , Collip JB, et al. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J, 1922; 12(3):141\u2013146.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108819"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.1987.tb07442.x"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0967772020974355"},{"key":"e_1_3_5_6_2","unstructured":"CMHF. Sir Frederick Banting MD. [cited 2024 Mar 12]. Available from: https:\/\/www.cdnmedhall.ca\/laureates\/frederickbanting"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0514"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/13591045231177115"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15073"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1132"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.7182\/pit2015789"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1962.tb45358.x"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2022.03.059"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198010000-00011"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.4.515"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0063"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/db23-836-P"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-201-4_3"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsac014"},{"key":"e_1_3_5_21_2","unstructured":"NobelPrize.org. [cited 2024 Mar 12]. The Nobel Prize in Physiology or Medicine 2012. Available from: https:\/\/www.nobelprize.org\/prizes\/medicine\/2012\/press-release\/"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1691"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.22-3-265"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.01044"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.2.301"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1077838"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1259"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1393"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3033"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.12.012"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01219-z"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108067"},{"issue":"12","key":"e_1_3_5_33_2","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro AMJ","year":"2021","unstructured":"Shapiro AMJ, , Thompson D, , Donner TW, et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep Med, 2021; 2(12). Available from: https:\/\/www.cell.com\/cell-reports-medicine\/abstract\/S2666-3791(21)00338-4","journal-title":"Cell Rep Med"},{"key":"e_1_3_5_34_2","first-page":"1","article-title":"Encapsulated stem cell\u2013derived \u03b2 cells exert glucose control in patients with type 1 diabetes","author":"Keymeulen B","year":"2023","unstructured":"Keymeulen B, , De Groot K, , Jacobs-Tulleneers-Thevissen D, , Thompson DM, , Bellin MD, , Kroon EJ, et al. Encapsulated stem cell\u2013derived \u03b2 cells exert glucose control in patients with type 1 diabetes. Nat Biotechnol., 2023; 1\u20138.","journal-title":"Nat Biotechnol."},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.146.3643.524"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.407649"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6776628"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/096368979500400413"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655139"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199606270-00002"},{"key":"e_1_3_5_41_2","unstructured":"Vertex Pharmaceuticals Incorporated. A phase 1\/2 Study to Evaluate the Safety Tolerability and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus. clinicaltrials.gov; Dec 2024 [cited 2025 Jan 18]. Report No.: NCT05791201. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05791201"},{"issue":"1","key":"e_1_3_5_42_2","article-title":"A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice","volume":"3","author":"Ajima K","year":"2023","unstructured":"Ajima K, , Tsuda N, , Takaki T, et al. A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice. Cell Rep Methods, 2023; 3(1):100370.","journal-title":"Cell Rep Methods"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00134"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.06.038"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiosc.2023.09.001"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90463-0"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/317230a0"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225829"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9935"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2631-z"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109538"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0686"},{"issue":"1","key":"e_1_3_5_54_2","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace D","year":"2023","unstructured":"Gerace D, , Zhou Q, , Kenty JH-R, et al. Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. Cell Rep Med, 2023; 4(1):100879.","journal-title":"Cell Rep Med"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.004"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3672-y"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-11-200406010-00009"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-068"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.148205"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0128"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13172859"},{"issue":"6","key":"e_1_3_5_62_2","first-page":"S47","article-title":"Screening for autoantibodies in type 1 diabetes: A call to action","volume":"70","author":"Peters A","year":"2021","unstructured":"Peters A. Screening for autoantibodies in type 1 diabetes: A call to action. J Fam Pract, 2021; 70(6S):S47\u2013S52.","journal-title":"J Fam Pract"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1419"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006136"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00019-X"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00139-X"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0494"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60886-6"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70111-6"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.1.123"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009356299"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.2000.1617"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00278-4"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199909150-00003"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115643"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.4.823"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.35.8.855"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012864"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2753-4"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60931-8"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8980"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1763"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0345"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308743"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00390-4"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2024.0498","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2024.0498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2024.0498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:15:11Z","timestamp":1777400111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2024.0498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1089\/dia.2024.0498"],"URL":"https:\/\/doi.org\/10.1089\/dia.2024.0498","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}